Ajooni Biotech Limited has informed the Exchange about the outcome of their board meeting on August 3, 2023. The approved transactions include un-audited financial results for the quarter ended June 30, 2023, an increase in authorized share capital, approval of draft directors report for the 2022-23 fiscal year, and appointment of a scrutinizer for the 13th Annual General Meeting.